Norman-Elvenich Alexander reported grant involving 31,202 derivative units of Matternet, Inc. at $0.00 for $0 on May 22, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Operating Officer
Chief Operating Officer
Filed May 27, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
31,202Employee Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
31,202Direct
Trade date
May 22, 2026Grant
Filed
May 27, 2026, 7:47 PM ET5-day reporting delay
Accession
0002128390-26-000004Code A · Transaction 89065
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

Returns since filing

Return windows need a valid ticker and filing date. Check the SEC source for missing filing facts.

Footnotes in full

F1: Received in connection with the Issuer's merger (the "Merger") with Matternet, Inc. ("Legacy Matternet") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated as of May 22, 2026, by and among the Issuer (f/k/a Los Altos Ventures Corp.), Matternet Acquisition Co. and Legacy Matternet (the "Merger Agreement"), in exchange for options of Legacy Matternet. Each vested and unvested option to purchase shares of common stock of Legacy Matternet outstanding immediately prior to the effective time of the Merger was assumed by the Issuer and converted into an option to purchase shares of common stock equal to the product of (a) the number of shares of common stock subject to such option immediately prior to the effective time of the Merger and (b) 2.0801 (the "Conversion Ratio"), at an exercise price per share equal to (i) the exercise price per share of such option immediately prior to the effective time of the Merger divided by (ii) the Conversion Ratio. F2: The shares subject to the option shall become vested and exercisable according to the following schedule: 25% of the shares subject to the option shall vest on the first anniversary of the vesting commencement date, and the remaining shares shall vest in equal monthly installments over the next 36 months. F3: The shares subject to the option shall become vested and exercisable in 48 equal monthly installments from the vesting commencement date.